Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-30 Sale | 2026-07-02 7:03 pm | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 10,000 | $34.9 | $349,000 | 81,541 (Direct) | View |
| 2026-06-29 Sale | 2026-07-01 6:34 pm | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 17,750 | $34.38 | $610,252 | 185,640 (Direct) | View |
| 2026-06-26 Sale | 2026-06-30 8:38 pm | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 1,638,163 | $34.46 | $56,444,076 | 15,437,569 (Indirect Direct) | View |
| 2026-06-26 Sale | 2026-06-30 8:30 pm | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 1,438,163 | $34.32 | $49,354,076 | 13,689,166 (Indirect) | View |
| 2026-06-26 Sale | 2026-06-30 7:59 pm | Roivant Sciences Ltd. | ROIV | QVT Financial LP Director by Deputization Director | 1,438,163 | $34.32 | $49,354,076 | 13,689,166 (Indirect) | View |
| 2026-06-25 Sale | 2026-06-29 6:23 pm | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 1,000,000 | $34.1 | $34,105,000 | 47,626,343 (Direct) | View |
| 2026-06-24 Sale | 2026-06-26 6:13 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $33.16 | $6,631,268 | 5,857,897 (Direct) | View |
| 2026-05-22 Sale | 2026-05-22 6:25 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $30.27 | $6,054,000 | 6,057,897 (Direct) | View |
| 2026-04-20 Sale | 2026-04-22 6:27 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $29.59 | $5,918,000 | 6,292,380 (Direct) | View |
| 2026-04-16 Sale | 2026-04-20 6:27 pm | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 289,774 | $29.16 | $8,449,810 | 16,736,116 (Direct) | View |
| 2026-04-08 Sale | 2026-04-10 6:00 pm | Roivant Sciences Ltd. | ROIV | Humes Jennifer Chief Accounting Officer | 13,538 | $28.37 | $384,073 | 84,191 (Direct) | View |
| 2026-03-26 Sale | 2026-03-30 9:01 pm | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 70,000 | $27.45 | $1,921,500 | 91,541 (Direct) | View |
| 2026-03-17 Sale | 2026-03-19 6:36 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $28.24 | $5,648,000 | 6,492,380 (Direct) | View |
| 2026-03-16 Sale | 2026-03-18 6:23 pm | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 41,861 | $28.68 | $1,200,573 | 15,804 (Direct) | View |
| 2026-02-19 Sale | 2026-02-23 8:40 pm | Roivant Sciences Ltd. | ROIV | Torti Frank President and Vant Chair | 3,000,000 | $27.35 | $82,039,460 | 25,002,489 (Direct) | View |
| 2026-02-13 Sale | 2026-02-18 5:57 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $26.49 | $5,298,000 | 6,699,431 (Direct) | View |
| 2026-02-11 Sale | 2026-02-13 9:02 pm | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 1,225,784 | $26.64 | $32,658,518 | 15,127,329 (Indirect) | View |
| 2026-02-11 Sale | 2026-02-13 9:00 pm | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 1,225,784 | $26.64 | $32,658,518 | 15,127,329 (Indirect) | View |
| 2026-02-11 Sale | 2026-02-13 8:45 pm | Roivant Sciences Ltd. | ROIV | QVT Financial LP Director by Deputization Director | 1,225,784 | $26.64 | $32,658,518 | 15,127,329 (Indirect) | View |
| 2026-02-09 Sale | 2026-02-11 5:53 pm | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 339,441 | $26.47 | $8,985,003 | 19,148,664 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-30 Tax Withholding | 2026-07-02 7:06 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 76,171 | $35.39 | 16,659,945 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 7:03 pm | N/A 2033-04-19 | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 10,000 | $0 | 81,541 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-02 7:03 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 10,000 | $8.8 | 81,541 (Direct) | View |
| 2026-06-30 Tax Withholding | 2026-07-02 7:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Torti Frank President and Vant Chair | 40,310 | $35.39 | 13,536,202 (Direct) | View |
| 2026-06-30 Tax Withholding | 2026-07-02 7:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 46,878 | $35.39 | 18,630,739 (Direct) | View |
| 2026-06-29 Exercise | 2026-07-01 6:34 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 17,750 | $4.46 | 185,640 (Direct) | View |
| 2026-06-29 Exercise | 2026-07-01 6:34 pm | N/A 2032-07-19 | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 17,750 | $0 | 185,640 (Direct) | View |
| 2026-06-25 Exercise | 2026-06-29 6:23 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 1,000,000 | $3.85 | 47,626,343 (Direct) | View |
| 2026-06-25 Exercise | 2026-06-29 6:23 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 1,000,000 | $0 | 47,626,343 (Direct) | View |
| 2026-06-24 Exercise | 2026-06-26 6:13 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $3.85 | 5,857,897 (Direct) | View |
| 2026-06-24 Exercise | 2026-06-26 6:13 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $0 | 5,857,897 (Direct) | View |
| 2026-06-20 Tax Withholding | 2026-06-23 9:17 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,129 | $31.43 | 276,420 (Direct) | View |
| 2026-06-20 Tax Withholding | 2026-06-23 9:16 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Humes Jennifer Chief Accounting Officer | 3,582 | $31.43 | 109,782 (Direct) | View |
| 2026-05-22 Exercise | 2026-05-22 6:25 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $3.85 | 6,057,897 (Direct) | View |
| 2026-05-22 Exercise | 2026-05-22 6:25 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $0 | 6,057,897 (Direct) | View |
| 2026-05-20 Tax Withholding | 2026-05-22 6:25 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 34,483 | $32.41 | 6,057,897 (Direct) | View |
| 2026-05-20 Tax Withholding | 2026-05-22 6:22 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 18,962 | $32.41 | 278,549 (Direct) | View |
| 2026-04-20 Exercise | 2026-04-22 6:27 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $3.85 | 6,292,380 (Direct) | View |
| 2026-04-20 Exercise | 2026-04-22 6:27 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $0 | 6,292,380 (Direct) | View |
| 2026-04-20 Option Award | 2026-04-22 6:26 pm | N/A 2036-04-19 | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 144,670 | $0 | 381,537 (Direct) | View |
| 2026-04-20 Option Award | 2026-04-22 6:26 pm | N/A 2036-04-19 | Roivant Sciences Ltd. | ROIV | Humes Jennifer Chief Accounting Officer | 56,330 | $0 | 140,521 (Direct) | View |
| 2026-04-17 Tax Withholding | 2026-04-21 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 95 | $29.83 | 120,229 (Direct) | View |
| 2026-04-17 Option Award | 2026-04-21 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 896 | $0 | 120,229 (Direct) | View |
| 2026-04-17 Option Award | 2026-04-21 6:34 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 670 | $0 | 16,474 (Direct) | View |
| 2026-04-17 Tax Withholding | 2026-04-21 6:32 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 94 | $29.83 | 109,405 (Direct) | View |
| 2026-04-17 Option Award | 2026-04-21 6:32 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 469 | $0 | 109,405 (Direct) | View |
| 2026-03-31 Tax Withholding | 2026-04-02 7:14 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Torti Frank President and Vant Chair | 160,035 | $27.7 | 13,576,512 (Direct) | View |
| 2026-03-30 Tax Withholding | 2026-04-01 7:20 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 53,826 | $26.41 | 17,025,890 (Direct) | View |
| 2026-03-31 Tax Withholding | 2026-04-01 7:20 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 304,684 | $27.7 | 17,025,890 (Direct) | View |
| 2026-03-30 Exercise | 2026-04-01 7:20 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 97,319 | $0 | 17,025,890 (Direct) | View |
| 2026-03-30 Exercise | 2026-04-01 7:20 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 2,178,150 | $11.5 | 17,025,890 (Direct) | View |
| 2026-03-30 Tax Withholding | 2026-04-01 7:19 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 29,809 | $26.41 | 18,677,617 (Direct) | View |
| 2026-03-31 Tax Withholding | 2026-04-01 7:19 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 187,512 | $27.7 | 18,677,617 (Direct) | View |
| 2026-03-30 Exercise | 2026-04-01 7:19 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 58,391 | $0 | 18,677,617 (Direct) | View |
| 2026-03-30 Exercise | 2026-04-01 7:19 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 1,306,889 | $11.5 | 18,677,617 (Direct) | View |
| 2026-03-26 Exercise | 2026-03-30 9:01 pm | N/A 2033-04-19 | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 70,000 | $0 | 91,541 (Direct) | View |
| 2026-03-26 Exercise | 2026-03-30 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 70,000 | $8.8 | 91,541 (Direct) | View |
| 2026-03-20 Tax Withholding | 2026-03-24 7:08 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 1,546 | $27.7 | 236,867 (Direct) | View |
| 2026-03-20 Tax Withholding | 2026-03-24 7:07 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Humes Jennifer Chief Accounting Officer | 14,526 | $27.7 | 97,729 (Direct) | View |
| 2026-03-17 Exercise | 2026-03-19 6:36 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $3.85 | 6,492,380 (Direct) | View |
| 2026-03-17 Exercise | 2026-03-19 6:36 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $0 | 6,492,380 (Direct) | View |
| 2026-02-20 Tax Withholding | 2026-02-24 6:43 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 1,000 | $27.15 | 238,413 (Direct) | View |
| 2026-02-20 Tax Withholding | 2026-02-24 6:43 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 7,051 | $27.15 | 1,647,546 (Direct) | View |
| 2026-02-19 Exercise | 2026-02-23 8:40 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Torti Frank President and Vant Chair | 3,000,000 | $3.85 | 25,002,489 (Direct) | View |
| 2026-02-19 Exercise | 2026-02-23 8:40 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Torti Frank President and Vant Chair | 3,000,000 | $0 | 25,002,489 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-18 5:57 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $3.85 | 6,699,431 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-18 5:57 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $0 | 6,699,431 (Direct) | View |
| 2026-02-09 Other | 2026-02-11 5:53 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 312,117 | $26.47 | 19,148,664 (Direct) | View |
| 2026-02-09 Exercise | 2026-02-11 5:53 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 651,558 | $12.68 | 19,148,664 (Direct) | View |
| 2026-02-09 Exercise | 2026-02-11 5:53 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 651,558 | $0 | 19,148,664 (Direct) | View |
| 2026-01-20 Tax Withholding | 2026-01-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 122 | $22.98 | 109,030 (Direct) | View |
| 2026-01-20 Option Award | 2026-01-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 609 | $0 | 109,030 (Direct) | View |
| 2026-01-20 Tax Withholding | 2026-01-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 124 | $22.98 | 119,428 (Direct) | View |
| 2026-01-20 Option Award | 2026-01-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 1,164 | $0 | 119,428 (Direct) | View |